INTEGRATED BIOPHARMA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
INTEGRATED BIOPHARMA INC (INBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 41.83 thousand shares for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 28.17K shares, a 74.37% decline year-over-year.
- INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was 36.67K shares, a 21856.29% increase year-over-year.
- INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-03-31 was 109.92K shares, a 54.47% decline year-over-year.
- INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-12-31 was 6.08K shares.
- INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 186.00K shares, a 23.01% decline from fiscal 2024.
- INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 241.60K shares, a 59.37% decline from fiscal 2023.
- INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 594.65K shares, a 1181.57% increase from fiscal 2022.
- INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 46.40K shares, a 26.54% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | 28.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | 41.83K shares 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 13.67K shares 10-Q · filed 2026-02-11 | ||||
| 2025-06-30 | 36.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | 146.58K shares derived: sum of 2 quarters · filed 2025-09-23 | 152.67K shares derived: sum of 3 quarters · filed 2025-09-23 | 186.00K shares 10-K · filed 2025-09-23 | |
| 2025-03-31 | 109.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | 116.00K shares derived: sum of 2 quarters · filed 2025-05-14 | 149.33K shares 10-Q · filed 2025-05-14 | 149.50K shares derived: sum of 4 quarters · filed 2025-09-23 | |
| 2024-12-31 | 6.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | 39.42K shares 10-Q · filed 2025-02-13 | 39.58K shares derived: sum of 3 quarters · filed 2025-09-23 | 281.02K shares derived: sum of 4 quarters · filed 2025-09-23 | |
| 2024-09-30 | 33.33K shares 10-Q · filed 2024-11-13 | 33.50K shares derived: sum of 2 quarters · filed 2025-09-23 | 274.93K shares derived: sum of 3 quarters · filed 2025-09-23 | 271.83K shares derived: sum of 4 quarters · filed 2025-09-23 | |
| 2024-06-30 | 167.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | 241.60K shares derived: sum of 2 quarters · filed 2025-09-23 | 238.50K shares derived: sum of 3 quarters · filed 2025-09-23 | 241.60K shares 10-K · filed 2025-09-23 | |
| 2024-03-31 | 241.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-10 | 238.33K shares derived: sum of 2 quarters · filed 2024-05-10 | 241.43K shares 10-Q · filed 2024-05-10 | ||
| 2023-12-31 | -3.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-12 | 0.00 shares 10-Q · filed 2024-02-12 | |||
| 2023-09-30 | 3.10K shares 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | 594.65K shares 10-K · filed 2024-09-20 | ||||
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-02-10 | ||||
| 2022-06-30 | 46.40K shares 10-K · filed 2023-09-15 | ||||
| 2021-12-31 | 0.00 shares 10-Q · filed 2022-02-10 | ||||
| 2021-06-30 | 36.67K shares 10-K · filed 2022-09-13 | ||||
| 2020-06-30 | 200.00K shares 10-K · filed 2021-09-02 | ||||
| 2019-06-30 | 343.25K shares 10-K · filed 2020-09-23 | ||||
| 2018-06-30 | 160.60K shares 10-K · filed 2019-08-29 | ||||
| 2017-06-30 | 51.10K shares 10-K · filed 2018-09-12 | ||||
| 2016-06-30 | 122.00K shares 10-K · filed 2017-09-01 | ||||
| 2015-06-30 | 881.57K shares 10-K · filed 2016-09-02 | ||||
| 2014-06-30 | 976.32K shares 10-K · filed 2015-09-04 | ||||
| 2013-06-30 | 92.50K shares 10-K · filed 2014-09-08 | -92.50K shares 10-K · filed 2013-09-30 | |||
| 2012-06-30 | -39.50K shares 10-K · filed 2013-09-30 | ||||
| 2011-06-30 | -270.00K shares 10-K · filed 2012-10-15 |